AN2 Therapeutics presents SOHO 2026 data on epetraborole for polycythemia vera
AN2 Therapeutics presented clinical and translational data supporting epetraborole development for polycythemia vera at the SOHO 2026 annual meeting.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.